Sign in

CIK 0001828673 · <br>Emerging growth company

HCW Biologics Inc.

Sign in to watch
Ticker
HCWB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
825024477
Phone
954-842-2024
Business address
2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
  1. 4 Grant or award Director acquired 35,714 shares (grant or award)
  2. 4 Grant or award Director acquired 35,715 shares (grant or award)
  3. 4 Grant or award Director acquired 142,858 shares (grant or award)
  4. 4 Grant or award SVP of Business Development acquired 71,429 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 760,714 shares (grant or award)
  6. 4 Option exercise See Remarks acquired 14,000 shares (option exercise)
  7. 4 Option exercise SVP of Business Development acquired 7,501 shares (option exercise)
  8. 4 Option exercise See Remarks acquired 15,000 shares (option exercise)
  9. 4 Option exercise Chief Financial Officer acquired 47,249 shares (option exercise)
  10. 4 Open-market buy Chief Executive Officer bought 1,800 shares at $2.08 ($3,741)
  11. 4 Open-market buy Director bought 1,587 shares at an average $2.05 ($3,256)
  12. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $2.10 ($10,490)
  13. 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $2.07 ($20,715)
  14. 4 Open-market buy Director bought 600 shares at an average $2.05 ($1,230)
  15. 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $1.99 ($19,853)
  16. 4 Open-market buy Director bought 463 shares at an average $1.78 ($823)
  17. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.95 ($9,749)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 6 · 109 filings